ACRV

NASDAQStock

Acrivon Therapeutics, Inc. Common Stock

$1.61+0.00 (+0.00%)

52-Week Range

$1.05

$5.61

Key Stats

Market Cap

50.8M

P/E Ratio

—

Dividend Yield

—

Beta

1.80

Volume

577.2K

Avg Volume

1.0M

Performance

-1.23%

-37.35%

+3.87%

YTD

-34.55%

-70.73%

-92.10%

-90.32%

Price Chart

ETF Exposure

ACRV is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.01%	45,466	$74K	$1.27B	0.60%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	26	$65	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	958	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	4	$11	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	545,541	$977K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	2,869	$7K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	247	$599	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	161,389	$289K	$84.10B	0.05%

About ACRV ETF Exposure

Acrivon Therapeutics, Inc. Common Stock (ACRV) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 50.8M, ACRV is a widely held institutional stock. The stock currently trades at $1.61. Investors can gain exposure to ACRV through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ACRV, sorted by portfolio weight.